The demand for wellness solutions continues to grow, but people are also looking for something more personal than a product on a shelf

Dyoung, accessed February 2, 2026, Revision of the legislation on supplementary protection certificates for plant protection products (RECAST) | Legislative Train Schedule European Parliament, accessed February 2, 2026, Implementation Of The Pharmaceutical Strategy For Europe And The Intellectual Property Action Plan Part 2 Maiwald GmbH, accessed February 2, 2026, A to Z: Drugs in Highlight Revisited Secerna, accessed February 2, 2026, More Than a Feeling: UPC, Rewriting the Score for Pharma at BIO 2025 Wolters Kluwer, accessed February 2, 2026, Beijing Supreme Peoples Court Upholds Novo Nordisk Semaglutide Patent in China based on Post-Filing Data Eagle IP, accessed February 2, 2026, China delivers a win for Novo Nordisk on semaglutide IP pharmaphorum, accessed February 2, 2026, Chinese drugmakers prep for looming semaglutide generics horizon, accessed February 2, 2026, Ozempics Patent Protection Starts to Expire in 2026

Both albiglutide and dulaglutide received FDA approval for the treatment of T2DM in 2014, with dulaglutide having an additional indication since 2020 to reduce the risk of major adverse cardiovascular events (MACE) in adults with T2DM and established cardiovascular disease or multiple cardiovascular risk factors [ Table 2 ]
Lund A, Knop FK, Vilsbll T
This blog explores the differences between B12 shot and pills, providing insights into why one might be more beneficial than the other